ArticleTrials2022

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial.

Jae-Yong Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.